Brian Taylor Slingsby sold $3.0M of Mineralys Therapeutics (MLYS)

Executed Sep 22, disclosed Sep 25, 2 days later.

Value, as filed

$3.0M

104,320 sh × $28.81

Executed

Sep 22

the trade date, as filed

Disclosed

Sep 25

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BS Brian Taylor Slingsby Director profile →

Brian Taylor Slingsby (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $43.4M of MLYS (1,000,000 sh × $43.35, as filed), executed Nov 20 2025.

The name

MLYS Mineralys Therapeutics, Inc. MLYS · Healthcare · 51 filings in 24 months ticker →

Healthcare · Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Brian Taylor Slingsby in MLYS

MLYSSALE Mineralys Therapeutics, Inc. $43.4M
1,000,000 sh × $43.35
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET MLYSPURCHASE Mineralys Therapeutics, Inc. $3.5M
259,259 sh × $13.50
Exec Mar 13 2025
Filed Apr 25 2025 · 5:30 PM ET †